Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: A nationwide cohort study

European Journal of Cancer

Volumn 50, Issue 2, 2014, Pages 447-456

  Nordholm Carstensen, Andreas ^a   Krarup, Peter Martin ^a   Jorgensen, Lars N ^a   Wille Jørgensen, Peer A ^a   Harling, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cohort study; Colorectal cancer; Lung neoplasms; Neoplasm metastasis

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; SELECTION BIAS; THORAX RADIOGRAPHY; VERY ELDERLY;

EID: 84891835906     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.10.009     Document Type: Article

References (38)

1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, and H. Comber et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 6 2013 1374 1403
2. M.S. Tsai, Y.H. Su, M.C. Ho, J.T. Liang, T.P. Chen, and H.S. Lai et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis Ann Surg Oncol 14 2 2007 786 794
3. S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, and A.M. Bouvier Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 2 2006 254 259
4. E. Mitry, B. Guiu, S. Cosconea, V. Jooste, J. Faivre, and A.M. Bouvier Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study Gut 59 10 2010 1383 1388
5. L. Weiss, E. Grundmann, J. Torhorst, F. Hartveit, I. Moberg, and M. Eder et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies J Pathol 150 3 1986 195 203
6. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. (eds.). SEER cancer statistics, review, 1975-2003; 2006.
7. J. Pfannschmidt, H. Dienemann, and H. Hoffmann Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series Ann Thorac Surg 84 1 2007 324 338
8. Danish Colorectal Cancer Group. Annual report 2009. 2011 Available from: http://dccg.dk/03-Publikation/02-arsraport-pdf/aarsrapport 2009.pdf [in Danish] [cited: 14.1.2.12].
9. L. Liu, E. de Vries, M. Louwman, K. Aben, M. Janssen-Heijnen, and M. Brink et al. Prevalence of multiple malignancies in the Netherlands in 2007 Int J Cancer 128 7 2011 1659 1667
10. M. Schmidt, J.B. Jacobsen, T.L. Lash, H.E. Botker, and H.T. Sorensen 25 Year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study BMJ 344 2012 e356
11. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383
12. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 4 1996 343 346
13. C.A. Bellera, G. MacGrogan, M. Debled, C.T. de Lara, V. Brouste, and S. Mathoulin-Pelissier Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer BMC Med Res Methodol 10 2010 20
14. T. Moreau, J. O'Quigley, and M. Mesbah A global goodness-of-fit statistic for the proportional hazards model Appl. Statist. 34 3 1985 212 218
15. R Development Core Team R. A language and environment for statistical computing. 2.15.2 ed.; 2008.
16. Therneau T. A package for survival analysis in S. R package version 2.37-2 ed.; 2012.
17. Gerds TA. Prodlim: product limit estimation for event history and survival analysis. R package version 1.3.2 ed.; 2012.
18. E.S. Hughes, and A.M. Cuthbertson Recurrence after curative excision of carcinoma of the large bowel JAMA 182 1962 1303 1306
19. The Danish Colorectal Cancer Group. Guidelines for the Management of Colorectal Cancer. 2010. Available from: http://dccg.dk/03-Publikation/ Retningslinier2009revOKT2010.pdf [in Danish] [updated 8.10.10].
20. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology rectal cancer 2013. Available from: http://www.nccn.org/ professionals/physician-gls/pdf/rectal.pdf [updated 28.11.12; cited 8.2.13].
21. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology colon cancer 2013. Available from: http://www.nccn.org/ professionals/physician-gls/pdf/colon.pdf [updated 28.11.12; cited 8.2.13].
22. The Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer 2007. Available from: http://www.acpgbi.org.uk/wp-content/uploads/2007-CC-Management-Guidelines.pdf [cited 8.2.13].
23. M.J. Kim, H.S. Lee, J.H. Kim, Y.J. Kim, J.H. Kwon, and J.O. Lee et al. Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer BMC Cancer 12 2012 347
24. C. Emmanouilides, G. Sfakiotaki, N. Androulakis, K. Kalbakis, C. Christophylakis, and A. Kalykaki et al. Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study BMC Cancer 7 2007 91
25. E. Van Cutsem, F. Rivera, S. Berry, A. Kretzschmar, M. Michael, and M. DiBartolomeo et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study Ann Oncol 20 11 2009 1842 1847
26. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, and W. Heim et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 23 2004 2335 2342
27. K. Hornbech, J. Ravn, and D.A. Steinbruchel Current status of pulmonary metastasectomy Eur J Cardiothorac Surg 39 6 2011 955 962
28. E. Internullo, S.D. Cassivi, D. Van Raemdonck, G. Friedel, and T. Treasure Pulmonary metastasectomy: a survey of current practice amongst members of the European society of thoracic surgeons J Thorac Oncol 3 11 2008 1257 1266
29. T. Treasure Pulmonary metastasectomy for colorectal cancer: weak evidence and no randomised trials Eur J Cardiothorac Surg 33 2 2008 300 302
30. F. Fiorentino, I. Hunt, K. Teoh, T. Treasure, and M. Utley Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis J R Soc Med 103 2 2010 60 66
31. H. Nozawa, E. Sunami, J. Nakajima, H. Nagawa, and J. Kitayama Synchronous and metachronous lung metastases in patients with colorectal cancer: a 20-year monocentric experience Exp Ther Med 3 3 2012 449 456
32. N. Damjanov, J. Weiss, and D.G. Haller Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease Oncologist 14 10 2009 963 969
33. C. Verhoef, J.H. de Wilt, J.W. Burger, H.M. Verheul, and M. Koopman Surgery of the primary in stage IV colorectal cancer with unresectable metastases Eur J Cancer 47 2011 S61 S66
34. A. Eisenberger, R.L. Whelan, and A.I. Neugut Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review Int J Colorectal Dis 23 6 2008 559 568
35. M.G. Scheer, C.E. Sloots, G.J. van der Wilt, and T.J. Ruers Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases Ann Oncol 19 11 2008 1829 1835
36. G.A. Poultsides, E.L. Servais, L.B. Saltz, S. Patil, N.E. Kemeny, and J.G. Guillem et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment J Clin Oncol 27 20 2009 3379 3384
37. G.H. Mickisch, A. Garin, H. van Poppel, L. de Prijck, and R. Sylvester Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 358 9286 2001 966 970
38. N.N. Rahbari, F. Lordick, C. Fink, U. Bork, A. Stange, and D. Jager et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS - a randomised controlled multicentre trial (ISRCTN30964555) BMC Cancer 12 2012 142